FLT3 and acute myeloid leukemia: Taken together, the preliminary analyses of FLT3 inhibitor treated patients support that ITD-AR and associated HLF gene expression changes can improve the prediction FLT3 inhibitor efficacy in adult FLT3-ITD+ AML.